These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29572483)

  • 21. The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway.
    Biswas PK; Park SR; An J; Lim KM; Dayem AA; Song K; Choi HY; Choi Y; Park KS; Shin HJ; Kim A; Gil M; Saha SK; Cho SG
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
    Guéripel X; Benahmed M; Gougeon A
    Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface.
    Yakymovych I; Yakymovych M; Zang G; Mu Y; Bergh A; Landström M; Heldin CH
    J Cell Biol; 2015 Jul; 210(2):319-32. PubMed ID: 26169354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of coronin 1B to TβRI negatively regulates the TGFβ1 signaling pathway.
    Kim GY; Lim HJ; Park HY
    Biochem Biophys Res Commun; 2017 Aug; 490(2):574-579. PubMed ID: 28625921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
    Luo K; Lodish HF
    EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
    Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
    Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor.
    Sundar R; Gudey SK; Heldin CH; Landström M
    Cell Cycle; 2015; 14(4):554-65. PubMed ID: 25622187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway.
    Lee IH; Sohn M; Lim HJ; Yoon S; Oh H; Shin S; Shin JH; Oh SH; Kim J; Lee DK; Noh DY; Bae DS; Seong JK; Bae YS
    Oncogene; 2014 Sep; 33(38):4675-84. PubMed ID: 24662814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the orphan GPR50 protein in rodent and human dorsomedial hypothalamus, tanycytes and median eminence.
    Sidibe A; Mullier A; Chen P; Baroncini M; Boutin JA; Delagrange P; Prevot V; Jockers R
    J Pineal Res; 2010 Apr; 48(3):263-269. PubMed ID: 20210849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
    Tazat K; Hector-Greene M; Blobe GC; Henis YI
    Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
    Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
    Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
    Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
    Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer.
    Mu Y; Sundar R; Thakur N; Ekman M; Gudey SK; Yakymovych M; Hermansson A; Dimitriou H; Bengoechea-Alonso MT; Ericsson J; Heldin CH; Landström M
    Nat Commun; 2011; 2():330. PubMed ID: 21629263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.
    Hachim MY; Hachim IY; Dai M; Ali S; Lebrun JJ
    Tumour Biol; 2018 Jan; 40(1):1010428317748254. PubMed ID: 29320969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
    Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
    Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
    Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM
    Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Smad signaling pathways.
    Mu Y; Gudey SK; Landström M
    Cell Tissue Res; 2012 Jan; 347(1):11-20. PubMed ID: 21701805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GPR50-Ctail cleavage and nuclear translocation: a new signal transduction mode for G protein-coupled receptors.
    Ahmad R; Lahuna O; Sidibe A; Daulat A; Zhang Q; Luka M; Guillaume JL; Gallet S; Guillonneau F; Hamroune J; Polo S; Prévot V; Delagrange P; Dam J; Jockers R
    Cell Mol Life Sci; 2020 Dec; 77(24):5189-5205. PubMed ID: 31900622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.